Market Cap 8.64M
Revenue (ttm) 0.00
Net Income (ttm) -14.50M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 1.32
Volume 24,400
Avg Vol 133,898
Day's Range N/A - N/A
Shares Out 5.61M
Stochastic %K 7%
Beta 1.98
Analysts Strong Sell
Price Target $17.00

Company Profile

Imunon, Inc., a clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines in the United States. The company's lead clinical program is IMNN-001, a DNA-based immunotherapy that is in a Phase 3 clinical trial for the localized treatment of advanced ovarian cancer, as well as in the IND-enabling phase for colorectal and pancreatic cancers, and in the discovery phase for glioblastoma. It is also developing IMNN-101, a COVID-19 booster vaccine that has completed a Phase...

Industry: Biotechnology
Sector: Healthcare
Phone: 609 896 9100
Website: imunon.com
Address:
997 Lenox Drive, Suite 100, Lawrenceville, United States
focafoca99
focafoca99 Sep. 9 at 4:19 PM
$IMNN outlined its R&D Day agenda and speaker lineup for September 23, showcasing IMNN-001 progress. https://www.rapidticker.com/news/imnn-imunon-announces-full-agenda-and-f7a361
0 · Reply
bomber1
bomber1 Sep. 3 at 10:08 AM
$IMNN According to Gemini, it seems to be the only major public event at the Sofitel New York in September; we shall see.
0 · Reply
bomber1
bomber1 Sep. 3 at 9:43 AM
$IMNN It is a shame that the New York hotel's September schedule lists key sessions with "Big Pharma" companies for September 13th—certainly not for the 23rd, which is merely a date to fill out the hotel's monthly conference calendar; just check the online schedule of events for September, and you will see for yourselves. I therefore predict nothing new—just like at all the previous conferences!
0 · Reply
Traders54
Traders54 Aug. 31 at 5:05 PM
$IMNN Oh, right; let's wait for September 23rd for the miracle...
1 · Reply
Sattamass
Sattamass Aug. 27 at 10:16 AM
$IMNN This share is a joke, the new low is just round the corner – forget all that rubbish about progress based on nothing! The management are desperate; they’ve run out of ideas on how to pump up a share that nobody gives a damn about – you only have to look at the trading volumes and the zero interest Tradotto con DeepL (https://dee.pl/apps)
1 · Reply
focafoca99
focafoca99 Aug. 26 at 12:45 PM
$IMNN prepares an R&D Day on Sep 23 to showcase its Phase 3 OVATION 3 trial of IMNN-001. https://www.rapidticker.com/news/imnn-imunon-to-host-2026-rd-2f8d25
0 · Reply
Jacks10
Jacks10 Aug. 25 at 2:21 PM
$IMNN MRNA move would suit me just fine!
0 · Reply
ConcernedCitizen23
ConcernedCitizen23 Aug. 25 at 2:20 PM
$IMNN a big upside move is long overdue
0 · Reply
Shrekislove69
Shrekislove69 Aug. 21 at 8:57 PM
$IMNN I mean if mRNA did what it did what’s stopping imnn. Hopefully the leadership makes some moves
0 · Reply
bxp2390
bxp2390 Aug. 21 at 6:21 PM
$IMNN And as a Friday present the stock is also threatening to close green - i might fall out of my chair if that does happen - but I suspect will close at our now-familiar $1.58 :-)
0 · Reply
Latest News on IMNN
Imunon Earnings Call Transcript: Q2 2026

Aug 11, 2026, 11:00 AM EDT - 4 weeks ago

Imunon Earnings Call Transcript: Q2 2026


Imunon Earnings release: Q2 2026

Aug 11, 2026, 11:00 AM EDT - 4 weeks ago

Imunon Earnings release: Q2 2026


Imunon Quarterly report: Q2 2026

Aug 11, 2026, 11:00 AM EDT - 4 weeks ago

Imunon Quarterly report: Q2 2026


Imunon reports Q2 EPS (54c), consensus (50c)

2026-08-11T12:11:11.000Z - 4 weeks ago

Imunon reports Q2 EPS (54c), consensus (50c)


Imunon provides update on OVATION 3 trial of IMNN-001

2026-07-30T13:22:48.000Z - 5 weeks ago

Imunon provides update on OVATION 3 trial of IMNN-001


Imunon announces new preliminary data from IMNN-001 trial

2026-07-21T13:25:28.000Z - 7 weeks ago

Imunon announces new preliminary data from IMNN-001 trial


Imunon Transcript: Life Sciences Virtual Investor Forum

Jun 25, 2026, 12:00 PM EDT - 2 months ago

Imunon Transcript: Life Sciences Virtual Investor Forum


Imunon Slides: Life Sciences Virtual Investor Forum

Jun 25, 2026, 12:00 PM EDT - 2 months ago

Imunon Slides: Life Sciences Virtual Investor Forum


Imunon Transcript: AGM 2026

Jun 16, 2026, 10:00 AM EDT - 2 months ago

Imunon Transcript: AGM 2026


IMUNON Announces Up to $10 Million Cash Financing

Jun 4, 2026, 8:00 AM EDT - 3 months ago

IMUNON Announces Up to $10 Million Cash Financing


Imunon reports Q1 EPS (84c), consensus ($1.28)

2026-05-12T16:03:21.000Z - 4 months ago

Imunon reports Q1 EPS (84c), consensus ($1.28)


Imunon Earnings Call Transcript: Q1 2026

May 12, 2026, 11:00 AM EDT - 4 months ago

Imunon Earnings Call Transcript: Q1 2026


Imunon Earnings release: Q1 2026

May 12, 2026, 11:00 AM EDT - 4 months ago

Imunon Earnings release: Q1 2026


Imunon Quarterly report: Q1 2026

May 12, 2026, 11:00 AM EDT - 4 months ago

Imunon Quarterly report: Q1 2026


Imunon Proxy statement: Proxy filing

May 4, 2026, 8:00 AM EDT - 4 months ago

Imunon Proxy statement: Proxy filing


Imunon initiated with a Buy at Maxim

2026-04-17T12:46:27.000Z - 4 months ago

Imunon initiated with a Buy at Maxim


Imunon Earnings Call Transcript: Q4 2025

Mar 31, 2026, 11:00 AM EDT - 5 months ago

Imunon Earnings Call Transcript: Q4 2025


Imunon Annual report: Q4 2025

Mar 31, 2026, 11:00 AM EDT - 5 months ago

Imunon Annual report: Q4 2025


Imunon Earnings release: Q4 2025

Mar 31, 2026, 11:00 AM EDT - 5 months ago

Imunon Earnings release: Q4 2025


Imunon Earnings Call Transcript: Q3 2025

Nov 13, 2025, 11:00 AM EST - 10 months ago

Imunon Earnings Call Transcript: Q3 2025


Imunon Quarterly report: Q3 2025

Nov 13, 2025, 11:00 AM EST - 10 months ago

Imunon Quarterly report: Q3 2025


Imunon Earnings release: Q3 2025

Nov 13, 2025, 11:00 AM EST - 10 months ago

Imunon Earnings release: Q3 2025


Imunon reports Q3 EPS ($1.16) vs ($3.76) last year

2025-11-13T12:50:55.000Z - 10 months ago

Imunon reports Q3 EPS ($1.16) vs ($3.76) last year


Imunon expects cash to fund operations into Q1 of 2026

2025-11-13T12:50:47.000Z - 10 months ago

Imunon expects cash to fund operations into Q1 of 2026


Imunon showcases progress on IMNN-001 at R&D Day

2025-11-10T13:00:28.000Z - 10 months ago

Imunon showcases progress on IMNN-001 at R&D Day


Imunon to present Phase 3 OVATION 3 study of IMNN-001

2025-10-30T12:21:17.000Z - 10 months ago

Imunon to present Phase 3 OVATION 3 study of IMNN-001


Imunon to present Phase 3 OVATION trial of IMNN-001

2025-10-14T12:36:43.000Z - 11 months ago

Imunon to present Phase 3 OVATION trial of IMNN-001


Imunon Earnings Call Transcript: Q2 2025

Aug 5, 2025, 11:00 AM EDT - 1 year ago

Imunon Earnings Call Transcript: Q2 2025


Imunon Quarterly report: Q2 2025

Aug 5, 2025, 11:00 AM EDT - 1 year ago

Imunon Quarterly report: Q2 2025


Imunon Earnings release: Q2 2025

Aug 5, 2025, 11:00 AM EDT - 1 year ago

Imunon Earnings release: Q2 2025


Imunon sees cash runway into 4Q25

2025-08-05T12:16:44.000Z - 1 year ago

Imunon sees cash runway into 4Q25


IMUNON Announces Stock Dividend Boosting Shareholder Value

Jul 28, 2025, 8:05 AM EDT - 1 year ago

IMUNON Announces Stock Dividend Boosting Shareholder Value


IMUNON Announces Reverse Stock Split

Jul 23, 2025, 8:00 AM EDT - 1 year ago

IMUNON Announces Reverse Stock Split


Imunon Transcript: Life Sciences Investor Forum

Jun 12, 2025, 11:30 AM EDT - 1 year ago

Imunon Transcript: Life Sciences Investor Forum


Imunon Proxy statement: Proxy Filing

Jun 9, 2025, 8:00 AM EDT - 1 year ago

Imunon Proxy statement: Proxy Filing


Imunon Registration statement: Registration Filing

May 30, 2025, 8:00 AM EDT - 1 year ago

Imunon Registration statement: Registration Filing


Imunon Proxy statement: Proxy Filing

May 30, 2025, 8:00 AM EDT - 1 year ago

Imunon Proxy statement: Proxy Filing


Imunon Registration statement: Registration Filing

May 19, 2025, 8:00 AM EDT - 1 year ago

Imunon Registration statement: Registration Filing


Imunon Registration statement: Registration Filing

May 13, 2025, 8:00 AM EDT - 1 year ago

Imunon Registration statement: Registration Filing


Imunon Earnings Call Transcript: Q1 2025

May 12, 2025, 11:00 AM EDT - 1 year ago

Imunon Earnings Call Transcript: Q1 2025


Imunon Quarterly report: Q1 2025

May 12, 2025, 11:00 AM EDT - 1 year ago

Imunon Quarterly report: Q1 2025


Imunon Earnings release: Q1 2025

May 12, 2025, 11:00 AM EDT - 1 year ago

Imunon Earnings release: Q1 2025


focafoca99
focafoca99 Sep. 9 at 4:19 PM
$IMNN outlined its R&D Day agenda and speaker lineup for September 23, showcasing IMNN-001 progress. https://www.rapidticker.com/news/imnn-imunon-announces-full-agenda-and-f7a361
0 · Reply
bomber1
bomber1 Sep. 3 at 10:08 AM
$IMNN According to Gemini, it seems to be the only major public event at the Sofitel New York in September; we shall see.
0 · Reply
bomber1
bomber1 Sep. 3 at 9:43 AM
$IMNN It is a shame that the New York hotel's September schedule lists key sessions with "Big Pharma" companies for September 13th—certainly not for the 23rd, which is merely a date to fill out the hotel's monthly conference calendar; just check the online schedule of events for September, and you will see for yourselves. I therefore predict nothing new—just like at all the previous conferences!
0 · Reply
Traders54
Traders54 Aug. 31 at 5:05 PM
$IMNN Oh, right; let's wait for September 23rd for the miracle...
1 · Reply
Sattamass
Sattamass Aug. 27 at 10:16 AM
$IMNN This share is a joke, the new low is just round the corner – forget all that rubbish about progress based on nothing! The management are desperate; they’ve run out of ideas on how to pump up a share that nobody gives a damn about – you only have to look at the trading volumes and the zero interest Tradotto con DeepL (https://dee.pl/apps)
1 · Reply
focafoca99
focafoca99 Aug. 26 at 12:45 PM
$IMNN prepares an R&D Day on Sep 23 to showcase its Phase 3 OVATION 3 trial of IMNN-001. https://www.rapidticker.com/news/imnn-imunon-to-host-2026-rd-2f8d25
0 · Reply
Jacks10
Jacks10 Aug. 25 at 2:21 PM
$IMNN MRNA move would suit me just fine!
0 · Reply
ConcernedCitizen23
ConcernedCitizen23 Aug. 25 at 2:20 PM
$IMNN a big upside move is long overdue
0 · Reply
Shrekislove69
Shrekislove69 Aug. 21 at 8:57 PM
$IMNN I mean if mRNA did what it did what’s stopping imnn. Hopefully the leadership makes some moves
0 · Reply
bxp2390
bxp2390 Aug. 21 at 6:21 PM
$IMNN And as a Friday present the stock is also threatening to close green - i might fall out of my chair if that does happen - but I suspect will close at our now-familiar $1.58 :-)
0 · Reply
bxp2390
bxp2390 Aug. 21 at 2:49 PM
$IMNN Time to open the champagne bottles, we're only down 2% in a month...
0 · Reply
Ferryf
Ferryf Aug. 20 at 10:35 AM
$IMNN FDA Approves Corcept’s Selective Glucocorticoid Receptor Antagonist Lifyorli™ (relacorilant) Plus Nab-Paclitaxel for Treatment of Patients with Platinum-Resistant Ovarian Cancer Lifyorli is the first FDA-approved selective glucocorticoid receptor antagonist (SGRA). with a median overall survival (OS) of 16.0 months, compared to 11.9 months for patients receiving nab-paclitaxel alone, a difference of 4.1 months What do you think if p3 successful
0 · Reply
Ferryf
Ferryf Aug. 20 at 10:32 AM
$IMNN Check $CORT ROSELLA – Pivotal Phase 3 trial of relacorilant plus nab-paclitaxel in 381 patients with platinum-resistant ovarian cancer – Both dual primary endpoints (progression-free and overall survival) met – Results published in The Lancet (Lorusso et al, April 2026) FDA approved Lifyorli (relacorilant) plus nab-paclitaxel for the treatment of patients with platinum-resistant ovarian cancer in March 2026 Lifyorli plus nab-paclitaxel added to the National Comprehensive Cancer Network Lifyorli™ product revenue of $47.6 million q226 Whats gone happen when P3 successful
0 · Reply
Traders54
Traders54 Aug. 20 at 9:33 AM
0 · Reply
Traders54
Traders54 Aug. 20 at 9:33 AM
$IMNN Moderna is up 170% on the stock market thanks to its Phase 3 mRNA vaccine trial involving 1,200 patients—but what is Imunon doing? It’s stringing its shareholders along; showing no signs of life; running trials with just two or three patients... What can we possibly hope for? We ought to go to their New Jersey headquarters and kick them in the backside...
1 · Reply
LKDOG
LKDOG Aug. 19 at 8:41 PM
$IMNN Curious if MRNA would add IMNN for ovarian .
0 · Reply
bxp2390
bxp2390 Aug. 19 at 5:16 PM
$IMNN Zacks report which came out today had $25 as price target, which is about 120 million market cap. Not impossible if these guys deliver on a partnership. But Zacks is mostly automated now, seems more like algorithms doing the analyses and putting out reports. That's both good and bad I guess, depending on how you see this versus human analysts. But not much movement in price as expected. Peace.
1 · Reply
ZacksSCR
ZacksSCR Aug. 19 at 4:12 PM
$IMNN: Strong Enrollment Momentum Continuing for Phase 3 OVATION 3 Trial https://buff.ly/xe26Pza
0 · Reply
STACKD0E
STACKD0E Aug. 19 at 4:10 PM
$IMNN 👁️
0 · Reply
ConcernedCitizen23
ConcernedCitizen23 Aug. 19 at 1:26 PM
$MRNA $IMNN Imunon is in phase 3 with 8 sites testing ovarian cancer treatment. Tiny compared to Moderna but phase 2 was slam dunk! Next to run?!?
1 · Reply
ConcernedCitizen23
ConcernedCitizen23 Aug. 19 at 11:46 AM
$IMNN amazing news from $MRNA and $MRK this am for melanoma. Ovarian cancer not mentioned for this mRNA technology! $IMNN still has the best new tech
1 · Reply
bxp2390
bxp2390 Aug. 16 at 1:39 AM
$IMNN And jjegglie, i understand where you stand and why you think this company cannot be trusted. You do have very valid points based on how Celsion went. Cant blame you for anything you say against anyone who seems to support them now. All i’m saying is that IMNN-001 is different. The market is clearly agreeing with you more than any of us, judging by the stock price freefall. But let’s just give this trial the time and see if some of us low probability bets turn out to be right here. Peace.
0 · Reply